// STATE LEGISLATION TRACKER

Minnesota SF 3035: Omnibus Jobs, Economic Development, Labor, and Industry appropriations

⚖️ MIXED for peptide users 👤 LOW user impact 📜 Status: Signed

State: Minnesota
Bill: SF 3035
Filed: 2023-03-22
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Minnesota SF3035 is a signed omnibus jobs, labor, and economic development law, not a health care or pharmacy bill. Its peptide relevance is narrow: it adds anti-doping rules for regulated combative sports that prohibit WADA-listed peptide hormones, growth factors, related substances, and mimetics unless an exception applies.

Key Points

No direct change to compounded peptide access or pharmacy rules.
No direct change to off-label prescribing, telehealth, NP, or naturopath scope.
Regulated combat-sport athletes face peptide hormone and growth-factor bans.
Drug testing may use urine, hair, or blood after weigh-in, contest day, or within 24 hours.
Positive tests or refusal can trigger discipline and change a win to no contest.

What to Watch For

Concern Combat-sport athletes using peptides should check whether a WADA exception applies before competing.

Note The bill does not appear to regulate FDA 503A/503B compounding or peptide prescribing.

Note No prescription monitoring or controlled-substance peptide provisions were apparent from the bill text reviewed.

Where the Bill Stands

The bill passed both chambers and was approved by the governor on May 24, 2023, becoming Minnesota Session Law Chapter 53.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws